U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007

Vaccine

Volumn 31, Issue 10, 2013, Pages 1447-1452

  Chang, Soju ^a   O'Connor, Patrick M ^b   Slade, Barbara A ^c   Woo, Emily Jane ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Postlicensure safety; Reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines; Tetanus toxoid; VAERS

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TOXOID; HEPATITIS A VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PERTUSSIS VACCINE;

ADULT; ANAPHYLAXIS; ARTICLE; BELL PALSY; BRAIN DISEASE; CAUSE OF DEATH; CELLULITIS; CHILD; DEMYELINATING DISEASE; DIPHTHERIA; DRUG INDUCED HEADACHE; DRUG SAFETY; ENCEPHALITIS; FAINTNESS; FEMALE; FEVER; GROUPS BY AGE; GUILLAIN BARRE SYNDROME; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; INFLUENZA B; INJECTION SITE REACTION; LICENSING; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERICARDITIS; PERTUSSIS; PRIORITY JOURNAL; SAFETY; SCHOOL CHILD; SEIZURE; SYMPTOM; TETANUS; THROMBOCYTOPENIA; UNITED STATES; VACCINATION; VIRUS MENINGITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DRUG TOXICITY; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 84875809589     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.097     Document Type: Article

References (29)

1. Broder K.R., Cortese M.M., Iskander J.K., et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 55(March (RR-3)):1-34.
2. Centers for Disease Control Prevention (CDC) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep 2011, 60(January (1)):13-15.
3. Food and Drug Administration (FDA). Complete list of vaccines licensed for immunization and distribution in the US, Product information, ; 2012 [accessed 22.10.12]. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM093833.
4. Chen R.T., Rastogi S.C., Mullen J.R., et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine 1994, 12(May (6)):542-550.
5. Food and Drug Administration (FDA). Postmarketing safety reporting requirements for drug and biologic products, ; 2012 [accessed 22.10.12]. http://www.fda.gov/Drugs/DrugSafety/ucm299833.htm.
6. The Brighton Collaboration. Case definitions. ; 2012 [accessed 22.10.12]. https://brightoncollaboration.org/public/what-we-do/standards/case-definitions.html.
7. Arness M.K., Eckart R.E., Love S.S., et al. Myopericarditis following smallpox vaccination. Am J Epidemiol 2004, 160(October (7)):642-651.
8. Braun M.M., Patriarca P.A., Ellenberg S.S. Syncope after immunization. Arch Pediatr Adolesc Med 1997, 151(March (3)):255-259.
9. Zhou W., Pool V., DeStefano F., Iskander J.K., Haber P., Chen R.T. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001. Pharmacoepidemiol Drug Saf 2004, 13(August (8)):505-510.
10. Ray P., Hayward J., Michelson D., et al. Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study. Pediatr Infect Dis J 2006, 25(September (9)):768-773.
11. Institute of Medicine. Vaccine Safety Committee: adverse events associated with childhood vaccines: evidence bearing on causality 1994, National Academies Press, Washington, DC. K.R. Stratton, C.J. Howe, R.B. Johnston (Eds.).
12. Zhou W., Pool V., Iskander J.K., et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001. MMWR Surveill Summ 2003, 52(January (1)):1-24.
13. Slade B.A., Leidel L., Vellozzi C., et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 2009, 302(August (7)):750-757.
14. Institute of Medicine. Committee to review adverse effects of vaccines. Board on Population Health and Public Health Practice. Adverse effects of vaccines: evidence and causality 2012, The National Academies Press, Washington, DC. K.R. Stratton, A. Ford, E. Rusch, E.W. Clayton (Eds.).
15. Dilber E., Karagoz T., Aytemir K., et al. Acute myocarditis associated with tetanus vaccination. Mayo Clin Proc Nov 2003, 78(11):1431-1433.
16. Amsel S.G., Hanukoglu A., Fried D., Wolyvovics M. Myocarditis after triple immunisation. Arch Dis Child 1986, 61(April (4)):403-405.
17. Boccara F., Benhaiem-Sigaux N., Cohen A. Acute myopericarditis after diphtheria, tetanus, and polio vaccination. Chest 2001, 120(August (2)):671-672.
18. Helle E.P., Koskenvuo K., Heikkila J., Pikkarainen J., Weckstrom P. Myocardial complications of immunisations. Ann Clin Res 1978, 10(October (5)):280-287.
19. Wu S.J., Sun S., Li J.Y., Hu P.Y., Chien C.Y. Acute fulminant myocarditis after diphtheria, polio, and tetanus vaccination. Asian Cardiovasc Thorac Ann 2006, 14(December (6)):e111-e112.
20. Tuttle J., Chen R.T., Rantala H., Cherry J.D., Rhodes P.H., Hadler S. The risk of Guillain-Barre syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. Am J Public Health 1997, 87(December (12)):2045-2048.
21. Mutsch M., Zhou W., Rhodes P., et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004, 350(February (9)):896-903.
22. Bohlke K., Davis R.L., Marcy S.M., et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003, 112(October (4)):815-820.
23. Centers for Disease Control Prevention (CDC) Syncope after vaccination - United States, January 2005-July 2007. MMWR Morb Mortal Wkly Rep 2008, 57(May 17):457-460.
24. Centers for Disease Control Prevention (CDC) General recommendations on immunization - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011, 60(January (2)):1-64.
25. Cohen A.D., Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmun 1996, 9(December (6)):699-703.
26. Woo E.J., Wise R.P., Menschik D., et al. Thrombocytopenia after vaccination: case reports to the US Vaccine Adverse Event Reporting System, 1990-2008. Vaccine 2011, 29(February (6)):1319-1323.
27. Kohl K.S., Gidudu J., Bonhoeffer J., et al. The development of standardized case definitions and guidelines for adverse events following immunization. Vaccine 2007, 25(August (31)):5671-5674.
28. Food and Drug Administration (FDA). Guidance for industry: good pharmacovigilance practices and pharmacoepidemiologic assessment. ; 2012 [accessed 22.10.12]. http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM126834.pdf.
29. Centers for Disease Control Prevention (CDC) Suspension of rotavirus vaccine after reports of intussusception - United States, 1999. MMWR Morb Mortal Wkly Rep 2004, 53(September (34)):786-789.